GE HealthCare Technologies Inc. $GEHC Shares Purchased by Vontobel Holding Ltd.

Vontobel Holding Ltd. raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 29.9% during the third quarter, Holdings Channel reports. The institutional investor owned 28,187 shares of the company’s stock after buying an additional 6,496 shares during the period. Vontobel Holding Ltd.’s holdings in GE HealthCare Technologies were worth $2,117,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of GEHC. Allianz SE increased its holdings in shares of GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after acquiring an additional 218 shares during the last quarter. Gladwyn Financial Advisors Inc. acquired a new position in GE HealthCare Technologies in the second quarter valued at approximately $34,000. Game Plan Financial Advisors LLC increased its stake in GE HealthCare Technologies by 295.3% in the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after purchasing an additional 375 shares during the last quarter. N.E.W. Advisory Services LLC raised its holdings in GE HealthCare Technologies by 75.2% during the second quarter. N.E.W. Advisory Services LLC now owns 545 shares of the company’s stock worth $40,000 after purchasing an additional 234 shares in the last quarter. Finally, HFM Investment Advisors LLC purchased a new stake in shares of GE HealthCare Technologies during the 1st quarter worth approximately $60,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $83.61 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a market capitalization of $38.09 billion, a price-to-earnings ratio of 17.27, a PEG ratio of 3.48 and a beta of 1.10. The company has a 50-day simple moving average of $78.74 and a 200-day simple moving average of $75.81. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.89%.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. BTIG Research reaffirmed a “buy” rating and issued a $87.00 target price on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Wells Fargo & Company dropped their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday, October 30th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 30th. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Finally, Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $87.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.